Hemo Organic Limited (BSE: 524590) is a Ahmedabad, Gujarat-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹8 Cr, it ranks #5,167 by market cap among the 6,137 Indian listed companies on FinBizNet, and #85 of 86 in Medicinal Chemicals and Botanical Products. At ₹22.97 (as of 25 Oct 2026), the share price is 5.9% below its 52-week high of ₹24.42 and 182.9% above its 52-week low of ₹8.12. The share price is up 144.6% over one year and down 5.9% over three months.
| Current Price | ₹22.97 |
|---|---|
| Market Cap | ₹8 Cr |
| BSE Code | 524590 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products |
| P/E Ratio | -10.2 |
| Return on Equity | 83.67% |
| Return on Assets | -6.60% |
| 52-Week Range | ₹8.12 – ₹24.42 |
| 1-Year Price Change | +144.6% |
| 3-Month Price Change | -5.9% |
| Beta (1Y) | -0.14 |
| Headquarters | Ahmedabad, Gujarat |
| Website | www.hemoorganic.co |
Hemo Organic Limited engages in the buying, selling, reselling, importing, exporting, transporting, storing, developing, promoting, supplying, marketing, and dealing of the agricultural products in India and internationally. It trades in wheat, rice, and maize; vegetables, including capsicum, tomato, green chili, potato, cucumber, and onion; and fruits, such as apple, red dragon fruit, sweet lime, and pomegranate. The company was formerly known as Dinesh Allorga Limited and changed its name to Hemo Organic Limited in August 2013. The company was incorporated in 1992 and is based in Ahmedabad, India.
1. Manufacturing of Bio Coal-This segment manufactures ayurvedic or unani pharmaceutical preparations. 2. Pharmaceuticals-This segment engages in the production and sale of white coal.
1. Trading and Distribution-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4,21,995 Cr | 36.4 | 14.72% | ₹15,300 Cr | +5.4% |
| Zydus Lifesciences Ltd | ₹1,12,020 Cr | 22.2 | 18.32% | ₹8,017 Cr | +14.7% |
| Laurus Labs Ltd | ₹1,11,310 Cr | 125.3 | 17.74% | ₹2,026 Cr | +125.7% |
| Cipla Limited | ₹1,07,048 Cr | 27.6 | 11.74% | ₹7,119 Cr | -14.7% |
| Dr.Reddys Lab | ₹1,02,611 Cr | 24.1 | 11.52% | ₹8,698 Cr | -0.9% |
| Aurobindo Pharma Ltd. | ₹95,910 Cr | 26.8 | 9.93% | ₹9,150 Cr | +41.7% |
| Mankind Pharma | ₹93,977 Cr | 48.7 | 12.45% | ₹4,031 Cr | -9.9% |
| Lupin Ltd | ₹89,426 Cr | 16.6 | 26.91% | ₹8,277 Cr | -1.1% |
| Hemo Organic Limited | ₹8 Cr | -10.2 | 83.67% | — | +144.6% |
Listed by market capitalisation. Ratios are shown for context only.
Hemo Organic Limited is trading at ₹22.97, with a market capitalisation of ₹8 Cr.
Hemo Organic Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).
Hemo Organic Limited has a P/E of -10.2 and a return on equity of 83.67%.
Hemo Organic Limited is listed on the BSE under the scrip code 524590.
Hemo Organic Limited's share price is up 144.6% over one year and down 5.9% over three months. Its 52-week range is ₹8.12 to ₹24.42.
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.